81 FR 96457 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 251 (December 30, 2016)

Page Range96457-96459
FR Document2016-31740

The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the revision of the information collection entitled ``Colorectal Cancer Control Program (CRCCP) Monitoring Activities.'' The change to the collection will include a redesigned survey and a redesigned clinic-level data collection template.

Federal Register, Volume 81 Issue 251 (Friday, December 30, 2016)
[Federal Register Volume 81, Number 251 (Friday, December 30, 2016)]
[Notices]
[Pages 96457-96459]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-31740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-17-1074; Docket No. CDC-2016-0123]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the revision of 
the information collection entitled ``Colorectal Cancer Control Program 
(CRCCP) Monitoring Activities.'' The change to the collection will 
include a

[[Page 96458]]

redesigned survey and a redesigned clinic-level data collection 
template.

DATES: Written comments must be received on or before February 28, 
2017.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0123 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Colorectal Cancer Control Program (CRCCP) Monitoring Activities--
(OMB Control No. 0920-1074, exp. 6/30/2018)--Revision--National Center 
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a revision of the information collection approved 
under OMB Control Number 0920-1074. Based on feedback from grantees and 
internal subject matter experts, CDC proposes use of a revised annual 
grantee survey instrument, as well as a revised clinic-level data 
collection template. The number of respondents will also decrease from 
31 to 30 grantees. Total estimated annualized burden will decrease. OMB 
approval is requested for three years.
    Colorectal cancer (CRC) is the second leading cause of death from 
cancer in the United States among cancers that affect both men and 
women. CRC screening has been shown to reduce incidence of and death 
from the disease. Screening for CRC can detect disease early when 
treatment is more effective and prevent cancer by finding and removing 
precancerous polyps. Of individuals diagnosed with early stage CRC, 
more than 90% live five or more years. Despite strong evidence 
supporting screening, only 65% of adults currently report being up-to-
date with CRC screening as recommended by the U.S. Preventive Services 
Task Force, with more than 22 million age-eligible adults estimated to 
be untested. To reduce CRC morbidity, mortality, and associated costs, 
use of CRC screening tests must be increased among age-eligible adults 
with the lowest CRC screening rates.
    CDC's Colorectal Cancer Control Program (CRCCP) currently provides 
funding to 30 grantees under ``Organized Approaches to Increase 
Colorectal Cancer Screening'' (CDC-RFA-DP15-1502). CRCCP grantees 
include state governments or bona-fide agents, universities, and tribal 
organizations. The purpose of the cooperative agreement program is to 
increase CRC screening rates among an applicant defined target 
population of persons 50-75 years of age within a partner health system 
serving a defined geographical area or disparate population. The CDC 
significantly redesigned the CRCCP in 2015. The CRCCP has two 
components.
    Component 1: Funding for component 1 is limited to partnerships 
with health systems to implement up to four priority evidence-based 
interventions (EBIs) described in the Guide to Community Preventive 
Services as well as other supporting strategies. Grantees must 
implement at least two EBIs in each partnering health system. All 30 
CRCCP grantees received Component 1 funding.
    Component 2: Funding for component 2 is used by grantees to provide 
direct screening and follow-up clinical services for a limited number 
of individuals aged 50-64 in the program's priority population who are 
asymptomatic, at average risk for CRC, have inadequate or no health 
insurance for CRC screening, and are low income. Six of the 30 CRCCP 
grantees received Component 2 funding.
    Two forms of data collection have been implemented to assess 
program processes and outcomes. In Program Year 1, the annual grantee 
survey monitored grantee program implementation, including (1) program 
management, (2) implementation of the EBIs and Supporting Activities 
(SAs) (3) health information technology (IT), (4) partnerships, (5) 
data use, (6) training and technical assistance (TA), and (7) clinical 
service delivery (for programs receiving Component 2 funding only). 
Clinic-level data collection assessed CRCCP's primary outcome of 
interest--CRC screening rates within partner health systems--by 
measuring the following components: (1) Partner health system, clinic, 
and patient population characteristics, (2) reporting period (for 
screening rates), (3) Chart review screening rate data, (4) Electronic 
Health Record (EHR)

[[Page 96459]]

screening rate, and (5) Priority evidence-based EBIs and SAs. CRCCP 
grantees collected and reported CRCCP clinic-level information for all 
partnering health system primary care clinic sites.
    For Program Years 2-5, based on feedback from grantees, CDC 
proposes use of updated data collection instruments. Specifically, CDC 
plans to implement a revised CRCCP annual grantee survey that 
eliminates survey items related to implementation of EBIs and SAs as 
these data are more accurately reported at the clinic level. 
Conversely, CDC plans to implement a revised CRCCP clinic-level data 
collection template that includes additional data variables related to 
implementation of EBIs and SAs, as well as monitoring and evaluation 
activities, at the clinic level.
    Redesigned data elements will enable CDC to better gauge progress 
in meeting CRCCP program goals and monitor implementation activities, 
evaluate outcomes, and identify grantee technical assistance needs. In 
addition, data collected will inform program improvement and help 
identify successful activities that need to be maintained, replicated, 
or expanded.
    OMB approval is requested for three years. The number of grantees 
decreased from 31 grantees in program year one to 30 grantees in 
program year two. In addition, the total estimated annualized burden 
hours have decreased from 210 to 204 hours. There are no costs to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees................  CRCCP Annual                  30               1           24/60              12
                                 Grantee Survey.
                                CRCCP Clinic-                 30              12           32/60             192
                                 level
                                 Information
                                 Collection
                                 Template.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             204
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-31740 Filed 12-29-16; 8:45 am]
 BILLING CODE 4163-18-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesWritten comments must be received on or before February 28, 2017.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS- D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation81 FR 96457 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR